Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer

Journal of Clinical Pathology

Volumn 56, Issue 10, 2003, Pages 764-768

  Leelawat, K ^a   Watanabe, T ^b   Nakajima, M ^b   Tujinda, S ^a   Suthipintawong, C ^a   Leardkamolkarn, V ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN RCAS1; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER STAGING; CARCINOGENESIS; COLON SURGERY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM SURGERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; THAILAND; UPREGULATION;

ANALYSIS OF VARIANCE; ANTIGENS, NEOPLASM; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0141987936     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.10.764     Document Type: Article

References (16)

1. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7.
3. Kinzler KW, Vogelstein B. Colorectal tumors. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York: McGraw Hill, 1998:565-87.
4. Boon T, Coulie PG, Van den B. Tumor antigens recognized by T cells. Immunol Today 1997;18:267-8.
5. O'Connell J, Bennett MW, Nally K, et al. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. Ann N Y Acad Sci 2000;10:178-92.
6. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999;5:938-42.
7. Sonoda K, Nakashima M, Kaku T, et al. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996;77:1501-9.
8. Sonoda K, Kaku T, Kamura T, et al. Tumor-associated antigen 22-1-1 expression in uterine cervical squamous neoplasia. Clin Cancer Res 1998;4:1517-20.
9. Rousseau J, Tetu B, Caron D, et al. RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun 2002;293:1544-9.
10. Nakakubo Y, Hida Y, Miyamoto M, et al. The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Lett 2002;177:101-5.
11. Enjoji M, Nakashima M, Nishi H, et al. The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract. J Hepatol 2002;36:786-92.
12. Suzuki M, Hida Y, Miyamoto M, et al. RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma. Ann Surg Oncol 2002;9:388-93.
13. Iwasaki T, Nakashima M, Watanabe T, et al. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000;89:488-93.
14. Oizumi S, Yamazaki K, Nakashima M, et al. RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung. Oncology 2002;62:333-9.
15. Akashi T, Oimomi H, Nishiyama K, et al. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 2003;26:49-5.
16. Favre-Felix N, Fromentin A, Hammann A, et al. Cutting edge: the tumour counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway. J Immunol 2000;164:5023-7.